New hope for tough nerve cancer: experimental drug trial seeks to shrink tumors
NCT ID NCT04917042
Summary
This study is testing whether the drug tazemetostat can help control a rare and aggressive cancer called malignant peripheral nerve sheath tumor (MPNST) that has come back or spread. It is for patients aged 12 and older whose cancer has not responded to other treatments. The main goal is to see if the drug can shrink tumors and slow the cancer's progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL NERVE SHEATH TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.